Meibomian gland dysfunction
Conditions
Interventions
Control group:Eyelid-warming combined with meibomian gland expression once a week
Experimental group:Eyelid-warming combined with meibomian gland expression fortnightly
Sponsors
Xi 'an First Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Age >=18 years old and =1/3 5. OSDI>13 6. Subjects and their guardians can understand the content of this study and voluntarily sign.
Exclusion criteria
Exclusion criteria: 1.Severe systemic diseases such as hypertension, diabetes mellitus, rheumatological and immunological diseases. 2.Patients with acute ocular inflammation and infection. 3.Ocular surgery or ocular trauma within six months, or the presence of developmental abnormalities. 4.Those who are pregnant, breastfeeding or planning to have children. 5.Special working environments such as high heat, dryness, etc. 6.Those deemed unsuitable for enrolment by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Morphological parameters of the meibomian gland; | — |
Secondary
| Measure | Time frame |
|---|---|
| Dropout of meibomian gland;Ocular surface disease index;Meibomian glands yielding secretion score;Adverse event;Tear meniscus height;Non-invasive tearfilm break-up time;Eye dryness score; | — |
Countries
China
Contacts
Public ContactXiao Xianghua
Xi 'an First Hospital
Outcome results
None listed